Recombinant Human IL-9 #abs00812

abs00812-2ug

1-2 Weeks

138

abs00812-10ug

1-2 Weeks

344

abs00812-1mg

1-2 Weeks

6742

Species

Human

Source

Escherichia coli.

Format

pH 7.4, the concentrated solution was filtered through a 0.2 μm filter and then lyophilized in PBS. Let's generate a content that maintains the information from the original text but rearranges it in a different manner.

Properties

aa_sequence

Here is a rearranged version of the original text:
EDPASKCHCS IPSDNCTRPC QGCPTLAGIL DINFLINKMQ ANVTSCLCLG FSRVKKSVEV TTMQTRYPLI CEQPCNQTTA FSERLSQMTN LKNNKCPYFS GNALTFLKSL LEIFQKEKMR GMRGKI
And here is a version generated using the same information but with different phrasing:
The combination of EDPASKCHCS and IPSDNCTRPC creates a powerful tool, QGCPTLAGIL, for data management and analysis. Its effectiveness in tasks such as DINFLINKMQ and ANVTSCLCLG is impressive. FSRVKKSVEV and TTMQTRYPLI are particularly well-suited for handling complex data sets, while CEQPCNQTTA and FSERLSQMTN help with organization and communication. The platforms of LKNNKCPYFS, GNALTFLKSL, LEIFQKEKMR, and GMRGKI offer further capabilities for customization and automation.

Concentration

> 95 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The determined level of Recombinant Human IL-9 is below 1 EU/μg, as analyzed using the LAL method. To generate a highly similar content, we can rearrange the information as follows:
According to the LAL method analysis, the Recombinant Human IL-9 concentration is found to be less than 1 EU/μg.

Activity

The biological activity of the sample is equivalent to that of the standard. It has been verified that the sample exhibits full biological activity when compared to the standard.₅₀The specific activity of a certain protein, measured through a cell proliferation assay with human MO7e cells, has been found to be greater than 5.0 × 10 and its minimum detectable concentration is less than 0.2 ng/ml. These findings suggest that the protein under evaluation may possess potent biological activity, making it a promising candidate for further investigation in various applications.⁶ IU/mg.

Reconstitution

To ensure optimal results, we recommend briefly centrifuging the vial prior to opening in order to bring the contents to the bottom. The protein should be reconstituted in sterile, distilled water or an aqueous buffer containing 0.1% BSA to achieve a concentration of 0.1-1.0 mg/mL. Stock solutions can be divided into working aliquots and stored at ≤ -20 °C. Dilutions should be made in suitable buffered solutions.

Stability & Storage

It is recommended to store this lyophilized preparation at 2-8 °C, but for long-term storage, it should be kept at -20 °C. It is preferable to store it in a desiccated condition. Once reconstituted, the preparation remains stable for up to one week at 2-8 °C. To ensure maximum stability, it is advised to divide the reconstituted preparation into smaller working aliquots and store them at temperatures ranging from -20 °C to -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles.

Target

Accession

P15248

Gene IDs

3578

References

References

1. Renauld JC, Goethals A, Houssiau F, et al. 1990. J Immunol. 144:4235-41.

2. Kelleher K, Bean K, Clark SC, et al. 1991. Blood. 77:1436-41.